- Report
- October 2023
- 140 Pages
Global
From €3450EUR$3,599USD£2,883GBP
- Report
- April 2023
- 147 Pages
Global
From €4744EUR$4,949USD£3,964GBP
- Report
- February 2024
- 80 Pages
India
From €4554EUR$4,750USD£3,805GBP
- Report
- February 2024
- 111 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- February 2024
- 130 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- April 2023
- 120 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- April 2023
- 110 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- July 2021
- 111 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- September 2024
- 80 Pages
Saudi Arabia
From €3355EUR$3,500USD£2,804GBP
- Report
- August 2024
- 84 Pages
Egypt
From €3355EUR$3,500USD£2,804GBP
- Report
- October 2023
- 172 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- October 2023
- 189 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- April 2023
- 110 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- July 2022
- 225 Pages
Global
From €3451EUR$3,600USD£2,884GBP
- Report
- May 2022
- 80 Pages
Asia Pacific
From €1438EUR$1,500USD£1,202GBP
- Report
- May 2022
- 80 Pages
Europe
From €1438EUR$1,500USD£1,202GBP
- Report
- September 2024
- 105 Pages
Greece
From €2675EUR$2,989USD£2,313GBP
- Report
- September 2024
- 100 Pages
Argentina
From €2675EUR$2,989USD£2,313GBP
- Report
- September 2024
- 118 Pages
Italy
From €2675EUR$2,989USD£2,313GBP
- Report
- September 2024
- 28 Pages
United Kingdom
From €995EUR$1,112USD£860GBP

The Ibuprofen market is a segment of the Over the Counter (OTC) Drugs industry. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain, fever, and inflammation. It is available in a variety of forms, including tablets, capsules, gels, creams, and liquids. Ibuprofen is one of the most widely used OTC drugs, and is available in both generic and branded forms. It is often used to treat mild to moderate pain, as well as inflammation associated with arthritis and other conditions. Ibuprofen is also used to reduce fever and to treat menstrual cramps.
The Ibuprofen market is highly competitive, with a number of major players. Some of the leading companies in the market include Johnson & Johnson, Bayer, Pfizer, GlaxoSmithKline, and Novartis. Show Less Read more